Alnajjar Munther S, ZainAlAbdin Sham, Arafat Mosab, Skaik Sanaa, AbuRuz Salah
Department of Biopharmaceutics & Clinical Pharmacy, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, The United Arab Emirates University, Al Ain, United Arab Emirates.
Pharm Pract (Granada). 2022 Jan-Mar;20(1):2628. doi: 10.18549/PharmPract.2022.1.2628. Epub 2022 Jan 12.
Internationally, pharmacists have shown a pivotal role in alleviating the unprecedented spread of the COVID-19 as they are the first touchpoint to patients. The aim of this study to evaluate the UAE pharmacists' knowledge about and practice in the global COVID-19 pandemic.
A quantitative cross-sectional study was conducted during a period from August 2020 to January 2021. A well-designed standardized English-based questionnaire was developed based on current literature and employed for this study.
The results showed that 45.7% of the participated pharmacists expected to have a good level of knowledge about COVID-19 transmission, symptoms and treatment. Among the participated community pharmacists, around 25.7% educated their patients and 17.0% counseled the public about the current available therapeutic options for managing COVID-19 symptom. Most practiced activities hospital pharmacists (17.4%) was exploring new drug therapies or uses, while few hospital pharmacists (13.0%) participated in the antimicrobial stewardship programs and monitored antibiotic uses for COVID-19 cases and co-infections. Pharmacists at age ≥40 years old and have an experience of ≥10 years in the pharmacy field were more knowledgeable about COVID-19 with higher scores (p <0.001 and p= 0.001; respectively).
The study revealed an appropriate average knowledge and practice toward COVID-19 among community and hospital pharmacists.
在国际上，药剂师在缓解新冠疫情前所未有的传播方面发挥了关键作用，因为他们是患者的首个接触点。本研究旨在评估阿联酋药剂师对全球新冠疫情的了解及实践情况。
于2020年8月至2021年1月期间进行了一项定量横断面研究。基于当前文献设计了一份精心设计的标准化英文问卷，并用于本研究。
结果显示，45.7%的参与药剂师期望对新冠病毒的传播、症状和治疗有良好的了解。在参与的社区药剂师中，约25.7%对患者进行了教育，17.0%就当前可用于管理新冠症状的治疗选择向公众提供了咨询。医院药剂师开展最多的活动是探索新的药物疗法或用途（17.4%），而很少有医院药剂师（13.0%）参与抗菌药物管理计划并监测新冠病例及合并感染的抗生素使用情况。年龄≥40岁且在药学领域有≥10年经验的药剂师对新冠病毒的了解更多，得分更高（分别为p<0.0..1和p = 0.001）。
该研究揭示了社区和医院药剂师对新冠病毒有适当的平均了解程度和实践情况。
